From DCAT Value Chain Insights (VCI)
Dr. Kung has served as a member of Sagent's Board of Directors since May 2006.He is a founding member of Vivo Capital, LLC and has been the managing partner since February 1997. Prior to that, He held the positions of co-founder, Chairman and Chief Executive Officer of Genelabs Technologies, Inc. and co-founder of Cetus Immune Corporation (later acquired by its parent company, Cetus Corporation). He has served on the board of directors of the Emerging Company Governing Body of the Biotechnology Industry Organization (BIO); Mt. Jade Science and Technology Association, West Coast; and the Asian American Manufacturing Association. He was also appointed by the U.S. Secretary of Health and Human Services as a voting member of the National Biotechnology Policy Board.
Source: Sagent Pharmaceuticals
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription